Piramal Pharma has awarded its integrated media mandate to OMD India, part of Omnicom Media Group. Following a multi-round pitch, the agency has been selected to handle the mandate of scaling the brand through sharp, creative and forward-leaning communication efforts.
OMD India will lead the strategic marketing and media efforts for the company’s portfolio of OTC brands, including Lacto Calamine, Little’s, Tetmosol, Polycrol, and Women’s intimate health range like i-pill and i-activ, and will be managed out of the agency’s Mumbai office.
The agency will be responsible for deploying a plan to enhance the company’s presence across markets, boost brand salience, drive consumer engagement, and enable impact-driven marketing strategy to be a driver for business growth.
“We are excited to embark on this partnership with Piramal Consumer Healthcare, a company that mirrors our commitment to innovation and excellence,” said Anisha Iyer, CEO of OMD India. “This collaboration presents a significant opportunity to leverage our strategic acumen and deep market intelligence to elevate Piramal’s impressive portfolio of brands to new heights. Together, we aim to craft media strategies that go beyond visibility, building lasting trust and loyalty with consumers across India and shaping a future of sustained growth and impact.”
